Paul Hartmann AG (PHH2) fair value: what the stock is really worth
As of Nov 18, 2026: fair value (intrinsic value) of Paul Hartmann AG stock €278, price €187, upside +49.2%, quality 57 out of 100. Rating: undervalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Paul Hartmann AG
PHH2 · FCheap (33% below fair value) and solid company, but falling price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range €159.58 – €313.62 · fair‑value band €180.95 – €372.83 · the €186.50 price screens below the €278.23 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Paul Hartmann is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Wound Care, Incontinence Management, and Infection Management.
Show moreShow less
It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management products, such as hydro active wound and silicone SAP dressings, post-op dressings, nature care, adhesive fixation, non-adhesive fixation, gauze, sponges/tamponades, contact layers, absorption pads, cotton, and negative pressure wound therapy; compression, universal, zinc paste, and padding bandages; and hands, skin, surface, instruments, and equipment disinfection and hygiene products.
In addition, the company sells operating theater products, including surgical drapes, operating theater clothing, surgical gloves, surgical absorbents and instruments; various Mediset products; patient care products, such as hygiene and maternity products, examination gloves, and nursing care products; diagnostics, such as blood pressure monitors, scale, and thermometers; first aid products; and cotton wool and cosmetic products.
It sells its products under the CombiSet, DermaPlast, MoliCare, Sterillium, Veroval, and Zetuvit brands. Paul Hartmann AG was founded in 1818 and is headquartered in Heidenheim, Germany.
Stock analysis
Paul Hartmann AG (PHH2) currently trades at €186.50, while our model-based Fair Value estimate is €278.23, implying the stock looks roughly 33% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of €353.28 per share, and 18 of the 23 models we run sit above the €186.50 price.
Bear case: the Asset-Based group reads lowest at €35.87, and 5 of the 23 models stay below the price. Data coverage for this calculation is high.
Scenario range: €180.95 (bear) to €372.83 (bull), the price of €186.50 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Paul Hartmann AG reported revenue of €2.4B in FY2025 versus €2.3B in FY2021, a compound +1.6%/yr. Reported net income was €61.2M in FY2025, compounding −10.3%/yr from FY2021.
Key figures
Market cap €662M Small · P/E ratio 6.6 · P/S ratio 0.27 · EPS (TTM) €28.11 · Dividend yield 4.3% · Net margin 4.0% · Return on equity 8.6% · Return on assets (EBIT) 3.9% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (low confidence).
What moves the price
The share trades about 16% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at 49%, PHH2 screens cheaper than that median.
Fair Value models
All 23 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch PHH2, get fair value alerts →
Compare Paul Hartmann AG with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 199 stocks
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- Stock screener with 62 metrics
- Undervalued stocks: German Stocks
- Valuation of the Germany market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Solventum Corporation SOLV | $86.48 | $131.27 | +52% | vs PHH2 |
| EssilorLuxottica Société anonyme EL | €176.80 | €196.22 | +11% | vs PHH2 |
| Intuitive Surgical, Inc ISRG | $420.95 | $353.90 | −16% | vs PHH2 |
| Medline Inc MDLN | $39.16 | $28.59 | −27% | vs PHH2 |
| Alcon Inc ALC | CHF 63.32 | CHF 35.08 | −45% | vs PHH2 |
| Becton, Dickinson and Company BDX | $216.08 | $97.80 | −55% | vs PHH2 |
| Straumann Holding STMN | CHF 108.60 | CHF 45.50 | −58% | vs PHH2 |
| West Pharmaceutical Services, Inc WST | $404.02 | $139.22 | −66% | vs PHH2 |
| Sartorius Stedim Biotech S.A DIM | €228.60 | €54.82 | −76% | vs PHH2 |
| Sartorius Aktiengesellschaft SRT | €235.50 | €46.44 | −80% | vs PHH2 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Paul Hartmann AG (PHH2) overvalued or undervalued?
What is the fair value of PHH2?
What is the quality score of PHH2?
What is the price target for Paul Hartmann AG (PHH2)?
What is the Paul Hartmann AG stock forecast for 2026?
What is the revenue of Paul Hartmann AG (PHH2)?
Does Paul Hartmann AG pay a dividend?
How much is the dividend of Paul Hartmann AG (PHH2) and when is the ex-dividend date?
What growth is priced into Paul Hartmann AG (PHH2)?
What discount rate (WACC) does the fair value of PHH2 use?
What is a reverse DCF?
How much growth has Paul Hartmann AG (PHH2) delivered so far?
How fast is the sector of Paul Hartmann AG (PHH2) growing?
What is the free cash flow yield of Paul Hartmann AG (PHH2)?
What is the intrinsic value of Paul Hartmann AG (PHH2)?
Is Paul Hartmann AG stock overvalued or undervalued in 2026?
Is fair value the same as the market price of PHH2?
How much is Paul Hartmann AG worth?
What do the bullish and bearish scenarios say about PHH2?
What is the P/E ratio of PHH2?
How solid is the balance sheet of Paul Hartmann AG (PHH2)?
How far is PHH2 from its 52-week high?
Which stocks are comparable to Paul Hartmann AG?
Is Paul Hartmann AG stock attractive at the current price?
How is the fair value of PHH2 calculated?
Is it still worth investing in stocks now?
What is the share price of Paul Hartmann AG (PHH2)?
What should I pay attention to with Paul Hartmann AG right now?
Key figures of Paul Hartmann AG
How large is the market capitalisation of Paul Hartmann AG (PHH2)?
What is the P/S ratio of Paul Hartmann AG (PHH2)?
What are the earnings per share of Paul Hartmann AG (PHH2)?
What is the dividend yield of Paul Hartmann AG (PHH2)?
What is the net margin of Paul Hartmann AG (PHH2)?
What is the return on equity of Paul Hartmann AG (PHH2)?
What is the EBIT return on assets of Paul Hartmann AG (PHH2)?
What is the operating margin of Paul Hartmann AG (PHH2)?
How fast is revenue growing at Paul Hartmann AG (PHH2)?
How fast are earnings growing at Paul Hartmann AG (PHH2)?
How much net debt does Paul Hartmann AG (PHH2) carry?
Watch Paul Hartmann AG in the live analysis
One click puts Paul Hartmann AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.